Direct-to-Consumer Genetic Testing Market Size, Share, By Test Type (Nutrigenomics Testing, Carrier Testing, Wellness & Fitness Testing, Predictive Testing, and Others), By Technology Type (Whole Genome Sequencing (WGS), Exome Sequencing, Next-Generation Sequencing (NGS), and Others), By Service Provider (In-house Laboratories, Third-Party Providers, and Pharmaceutical Partnerships), By Application (Personalized Medicine, Clinical Diagnostics, Research Applications, and Consumer Insights), By Distribution Channel (Online Platforms, and Offline Platforms), and By Region - Trends, Analysis and Forecast till 2034

Direct-to-Consumer Genetic Testing Market Size was valued at US$ 2.8 billion in 2024 and is expected to grow at a CAGR of 24.5% to reach US$ 20.7 billion by 2034.

Direct-to-Consumer Genetic Testing Market refers to genetic tests that consumers can purchase directly from providers without the need for a healthcare provider's prescription or intervention. These tests offer individuals insights into their ancestry, health risks, traits and even potential genetic predispositions for various conditions. The process typically involves consumers ordering a test kit online, collecting a DNA sample (usually through saliva), and sending it back to the company for analysis.